SyntekaBio,Inc. Logo

SyntekaBio,Inc.

AI drug discovery platform accelerating R&D with supercomputing, SaaS, and pre-made candidates.

226330 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 국제과학17로 18 -, 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SyntekaBio is an AI-driven drug discovery company that utilizes its proprietary supercomputing infrastructure to accelerate the development of therapeutics. The company's core platform, DeepMatcher®, automates the process of identifying and optimizing drug candidates from hit screening to preclinical lead generation. SyntekaBio offers its technology through several business models: STB LaunchPad, a repository of pre-made, 'off-the-shelf' drug candidates for over 100 disease targets; end-to-end discovery and development services; and a suite of CLOUD-SaaS modules for specific applications like small molecule analysis (Sm-ARS), neoantigen prediction (NEO-ARS), and antibody design (Ab-ARS). This 'factory-like' approach aims to reduce the time and cost of pharmaceutical R&D for its partners.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SyntekaBio,Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SyntekaBio,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SyntekaBio,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan 190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden CHOSA
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan 4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan 7379
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom CIZ
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan 7059
A creator agency connecting professionals in creative, tech, medical, and legal sectors.
Japan 4763
Offers IT solutions to financial institutions and develops vaccines for HIV and coronaviruses.
South Korea 040350
CRG HOLDINGS CO.,LTD. Logo
Provides IT-driven HR services, outsourcing, system solutions, and financial advisory.
Japan 7041
CRONEX.CO.,LTD Logo
CRO supplying mini-pigs and bio-tissues for non-clinical R&D in medical and cosmetic industries.
South Korea 215570

Talk to a Data Expert

Have a question? We'll get back to you promptly.